Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 913-914, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (55)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swan, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swan, S. K.
Related Collections
Right arrow General Clinical Chemistry
(Clinical Chemistry. 1997;43:913-914.)
© 1997 American Association for Clinical Chemistry, Inc.


Editorials

The Search Continues—An Ideal Marker of GFR

Suzanne K. Swan

Division of Nephrology, Hennepin County Medical Center, 701 Park Ave., Minneapolis, MN 55415, Fax 612-347-2003

The glomerular filtration rate (GFR) is generally considered the best measure of renal function despite the fact that the kidney performs an array of duties, including salt and water balance, erythropoiesis, bone metabolism, electrolyte homeostasis, and blood pressure control. GFR is traditionally measured as the renal clearance of a particular substance from plasma and is expressed as the volume of plasma that can be completely cleared of that substance in a unit of time. The ideal marker for GFR determinations would appear endogenously in the plasma at a constant rate, be freely filtered at the glomerulus, be neither reabsorbed nor secreted by the renal tubule, and undergo no extrarenal elimination. Although the ideal marker for measuring GFR has yet to be found, these characteristics can be useful benchmarks for comparing the advantages and disadvantages of new methods for GFR quantification.

Measurement of urea marked the beginning of efforts to quantify renal function with its isolation by Rouelle in 1773 (1). Subsequently, Strauss introduced blood urea as a diagnostic test for renal disease in 1903. The concept of clearance as a measure of renal function followed in 1929 (2) and was subsequently extended to creatinine in the early 1930s (1).

Blood urea nitrogen (BUN) concentration is generally recognized . . . [Full Text of this Article]


References




The following articles in journals at HighWire Press have cited this article:


Home page
Am. J. Roentgenol.Home page
P.-A. Poletti, P. Saudan, A. Platon, B. Mermillod, A.-M. Sautter, B. Vermeulen, F. P. Sarasin, C. D. Becker, and P.-Y. Martin
IV N-Acetylcysteine and Emergency CT: Use of Serum Creatinine and Cystatin C as Markers of Radiocontrast Nephrotoxicity
Am. J. Roentgenol., September 1, 2007; 189(3): 687 - 692.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
W. Koenig, D. Twardella, H. Brenner, and D. Rothenbacher
Plasma Concentrations of Cystatin C in Patients with Coronary Heart Disease and Risk for Secondary Cardiovascular Events: More than Simply a Marker of Glomerular Filtration Rate
Clin. Chem., February 1, 2005; 51(2): 321 - 327.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
U. Hoffmann, M. Fischereder, B. Kruger, W. Drobnik, and B. K. Kramer
The Value of N-Acetylcysteine in the Prevention of Radiocontrast Agent-Induced Nephropathy Seems Questionable
J. Am. Soc. Nephrol., February 1, 2004; 15(2): 407 - 410.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G.D. Tan, A.V. Lewis, T.J. James, P. Altmann, R.P. Taylor, and J.C. Levy
Clinical Usefulness of Cystatin C for the Estimation of Glomerular Filtration Rate in Type 1 Diabetes: Reproducibility and accuracy compared with standard measures and iohexol clearance
Diabetes Care, November 1, 2002; 25(11): 2004 - 2009.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
O. F. Laterza, C. P. Price, and M. G. Scott
Cystatin C: An Improved Estimator of Glomerular Filtration Rate?
Clin. Chem., May 1, 2002; 48(5): 699 - 707.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. Risch, R. Herklotz, A. Blumberg, and A. R. Huber
Effects of Glucocorticoid Immunosuppression on Serum Cystatin C Concentrations in Renal Transplant Patients
Clin. Chem., November 1, 2001; 47(11): 2055 - 2059.
[Full Text] [PDF]


Home page
JNMHome page
K. Itoh
Determination of Glomerular Filtration Rate by Means of Newly Developed Plastic Scintillation Counter Both With and Without Dilution Procedures
J. Nucl. Med., October 1, 2001; 42(10): 1484 - 1488.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Stowe, D. Lawrence, D. J. Newman, and E. J. Lamb
Analytical Performance of a Particle-enhanced Nephelometric Immunoassay for Serum Cystatin C Using Rate Analysis
Clin. Chem., August 1, 2001; 47(8): 1482 - 1485.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. B Ubbink
Metabolic markers of vitamin nutritional status
Am. J. Clinical Nutrition, November 1, 1999; 70(5): 789 - 790.
[Full Text]


Home page
Clin. Chem.Home page
F. Priem, H. Althaus, M. Birnbaum, P. Sinha, H. S. Conradt, and K. Jung
ß-Trace Protein in Serum: A New Marker of Glomerular Filtration Rate in the Creatinine-Blind Range
Clin. Chem., April 1, 1999; 45(4): 567 - 568.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
D. Stickle, B. Cole, K. Hock, K. A. Hruska, and M. G. Scott
Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population
Clin. Chem., June 1, 1998; 44(6): 1334 - 1338.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.